|
| |
John Somerville (Bristol-Myers Squibb), Chair
Andrew Glasebrook (Eli Lilly and Company)
Arpita Maiti (Vertex)
Marcia Bliven (Pfizer, retired) |
|
|
Andrew Glasebrook (Eli Lilly and Company), Chair
Steven Simpson (GSK)
Ken Walsh (Boston Univ.)
Lisa Schopf (Abbott)
William Selig (Consultant)
Annalisa D'Andrea (SRI International Biosciences)
Liwu Li (Virginia Tech)
Laura Carter (Array BioPharma)
Joan Merrill (Oklahoma Medical Research Foundation)
Bruce Tomczuk (Arginetix)
Spencer Danto (Pfizer) |
|
|
Laurent Audoly (Merck)
Bassil Dahiyat (Xencor) |
|
|
Arpita Maiti (Vertex), Chair |
|
Poster Sessions/
Abstract Book/
Program
|
Ed Yurkow (J&J PRD), Chair
John Somerville (Bristol-Myers Squibb)
Marcia Bliven (Pfizer, retired) |
|
|
Marcia Bliven (Pfizer, retired), Chair
Joan Chapdelaine (Calvert Laboratories)
Richard McLaughlin (Rich McLaughlin & Assoc.)
Deborah Wolff (Novartis) |
|
|
Joan Chapdelaine (Calvert Laboratories) |
|
|
Marcia Bliven (Pfizer, retired)
Richard McLaughlin (Rich McLaughlin & Assoc.)
Deborah Wolff (Novartis) |
|
|
John Somerville (Bristol-Myers Squibb)
Lis Flynn (Visual Sound) |
|
|
Tineke Meijers (TNO Pharma) |
|
|
John Somerville (Bristol-Myers Squibb), Chair
Tineke Meijers (TNO Pharma) |
|
|
Howard Kartstein (Metabolon), Chair
Tineke Meijers (TNO Pharma) |
|
|
Arpita Maiti (Vertex), Chair
John Somerville (Bristol-Myers Squibb) |
|
C. Gordon Van Arman Scholarship Award Committee
|
Lisa Olson (Abbott Bioresearch Center), Chair
Caralee Schaefer (Intermune)
Jane Connor (MedImmune)
Jim Ellis (Sirtis Pharmaceuticals)
Liwu Li (Virginia Tech)
William Weslin (Avila)
Joel Tocker (Amgen) |
|
|
John Somerville (Bristol-Myers Squibb), Interim Chair |
|
Thomson Drugs Proceedings
|
Richard Griffiths (Pfizer) |
|
|
John Somerville (Bristol-Myers Squibb)
Andrew Glasebrook (Eli Lilly and Company) |
